ResMed Moves into South Korea

ResMed Moves into South Korea

Sleep apnea doesn’t discriminate. The condition occurs everywhere, and that’s where ResMed, Inc. (NYSE: RMD) is going. On March 8, the medical device maker bought HB Healthcare in Seoul, South Korea, for an undisclosed amount. HB provides home medical equipment provider and serves both reimbursed and cash-pay customers to assist with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions. The move comes after the Korean government’s July 2018 decision to begin National Health Insurance Service reimbursement for sleep apnea diagnosis and CPAP treatment devices. One in five Korean adults could have sleep apnea, according to a study by Ansan... Read More »
Propeller Health Flies to ResMed

Propeller Health Flies to ResMed

And Propeller Health makes three. Three deals in 2018, that is, for ResMed Inc. (NYSE: RMD), which picked up Propeller for $225 million on December 3. ResMed is a global medical device maker with more than 6 million cloud-connected devices for daily remote patient monitoring for conditions like sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Propeller Health is a digital therapeutics company based in Madison, Wisconsin and backed by Aptar Pharma, Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One. Its products treat COPD patients in Stage 2 and 3 severity levels through connectivity, analytics and companion digital experiences.... Read More »
ResMed Pays Big for MatrixCare

ResMed Pays Big for MatrixCare

It’s a frothy, frothy market in most areas of health care, and the digital health space just got frothier. ResMed Inc. (NYSE: RMD), which makes medical equipment to monitor respiratory disorders, announced it paid $750 million for MatrixCare, a portfolio company of OMERS Private Equity. Right up front, ResMed touted the 25x price/EBITDA multiple, based on MatrixCare’s pro forma net EBITDA of approximately $30 million for calendar year 2018. Pro forma net revenue of $122 million in the same period is approximately 6.2x. The valuation is higher than even the sector’s biggest deal this year, Verscend Technologies’ $4.9 billion take-private deal for Cotiviti Holdings... Read More »
ResMed Moves into South Korea

ResMed Adds HealthCareFirst to Home Health Solutions

Medical device maker ResMed (NYSE: RMD) is moving deeper into the Home Health & Hospice arena. The company announced its acquisition of HealthCareFirst, which provides software solutions for home health and hospice agencies. HealthCareFirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics to help agencies optimize their clinical, financial and administrative processes. Financial terms were not disclosed. Pamlico Capital is the seller, having acquired HealthCareFirst in September 2012 from The Riverside Company. ResMed’s devices and software solutions help to treat and manage sleep apnea, chronic obstructive pulmonary disease... Read More »
ResMed Moves into South Korea

Sleep Disorders Make for Steady Business

For all the companies and remedies devoted to sleep disorders, it’s a wonder they haven’t been cured by now. The latest deal targeting a company focused on sleep apnea and other conditions was announced last week, on April 11. SleepScore Labs, a medical device company based in Carlsbad, California, acquired the Dutch technology company Sleep.ai for an undisclosed amount. SleepScore Labs was founded in 2016 and is a joint venture between Dr. Mehmet Oz, ResMed (NYSE: RMD) and Pegasus Capital Advisors. It is focused on improving sleep and uses ResMed’s SleepScore technology. ResMed specializes in cloud-connected devices for daily remote patient monitoring, to help treat and... Read More »